← Leaderboards
William D Cress
H. Lee Moffitt Cancer Ctr & Res Inst
$7,111,958
Attributed
$9,840,659
Total exposure
11
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$11,037,773 · 12
By mechanism
R01$4,483,321 · 2
P01$1,679,626 · 2
T32$1,600,510 · 1
P20$1,594,619 · 2
U54$1,034,902 · 3
R21$429,318 · 1
Top collaborators
- Elsa R Flores6 shared
- Harold I Saavedra6 shared
- Brooke L Fridley5 shared
- Cathy D Meade4 shared
- Jamie K Teer2 shared
- Xuefeng Wang1 shared
Most similar at H. Lee Moffitt Cancer Ctr & Res Inst
Same institution · by research overlap
- Eric B. Haura$11,744,471
- Elsa R Flores$12,484,914
- John L. Cleveland$27,832,236
- Andrew Scott Brohl$746,439
- Kenneth Lynn Wright$8,797,565
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsCancer CenterMolecularTissue MicroarrayResearch PersonnelGenomicsTranscriptome SequencingTumorSpecimenMalignant Breast NeoplasmCancer Health DisparityGenesGene ExpressionDiagnosisBiobankResourcesEuropeanAfricanCollaborationsGeneticResource SharingPuerto RicoProgramsEthnic Origin
Grant awards (44)
Targeting centrosomeâmitotic kinases as a novel therapeutic approach against breast cancers in Hispanic/Latinas.$1,079,390
R01 · FY2025 · CA
Pre-Clinical Core$343,062
P01 · FY2025 · CA · contact PI
Targeting centrosomeâmitotic kinases as a novel therapeutic approach against breast cancers in Hispanic/Latinas.$239,942
R01 · FY2025 · CA
Shared Resource Core: Puerto Rico BioBank$147,266
U54 · FY2025 · CA · contact PI
Understanding the biology of an ADCK4-NUMBL fusion in lung adenocarcinoma aggressiveness$147,264
U54 · FY2025 · CA · contact PI
Targeting centrosomeâmitotic kinases as a novel therapeutic approach against breast cancers in Hispanic/Latinas.$486,917
R01 · FY2024 · CA
Pre-Clinical Core$325,908
P01 · FY2024 · CA · contact PI
Shared Resource Core: Puerto Rico BioBank$220,300
U54 · FY2024 · CA · contact PI
Targeting centrosome-mitotic kinases as a novel therapeutic approach against breast cancers in Hispanic/Latinas. Supplement1$117,166
R01 · FY2024 · CA
Targeting centrosomeâmitotic kinases as a novel therapeutic approach against breast cancers in Hispanic/Latinas.$487,437
R01 · FY2023 · CA
Pre-Clinical Core$336,200
P01 · FY2023 · CA · contact PI
Shared Resource Core: Puerto Rico BioBank$227,999
U54 · FY2023 · CA · contact PI
Integrated Program in Cancer and Data Science$211,392
T32 · FY2023 · CA · contact PI
Molecular Drivers of Lung Cancer in Hispanics$192,997
R21 · FY2023 · CA · contact PI
Targeting centrosomeâmitotic kinases as a novel therapeutic approach against breast cancers in Hispanic/Latinas.$483,219
R01 · FY2022 · CA
Integrated Program in Cancer and Data Science$441,104
T32 · FY2022 · CA · contact PI
Pre-Clinical Core$342,159
P01 · FY2022 · CA · contact PI
Molecular Drivers of Lung Cancer in Hispanics$236,321
R21 · FY2022 · CA · contact PI
Integrated Program in Cancer and Data Science$427,875
T32 · FY2021 · CA · contact PI
Pre-Clinical Core$332,297
P01 · FY2021 · CA · contact PI
Shared Resources Core: Puerto Rico Biobank$150,129
U54 · FY2021 · CA · contact PI
Cancer Research Workforce Development in FAIR Artificial Intelligence and Machine Learning$86,337
T32 · FY2021 · CA · contact PI
1/2 Southeast Partnership for Improving Research & Training in Cancer Health Disparities$301,544
P20 · FY2020 · CA
Integrated Program in Cancer and Data Science$294,797
T32 · FY2020 · CA · contact PI
Shared Resources Core: Puerto Rico Biobank$141,944
U54 · FY2020 · CA · contact PI
Research Pilot Project$96,957
P20 · FY2020 · CA · contact PI
1/2 Southeast Partnership for Improving Research & Training in Cancer Health Disparities$292,495
P20 · FY2019 · CA
Integrated Program in Cancer and Data Science$139,005
T32 · FY2019 · CA · contact PI
Research Pilot Project$95,477
P20 · FY2019 · CA · contact PI
1/2 Southeast Partnership for Improving Research & Training in Cancer Health Disparities$301,538
P20 · FY2018 · CA
Research Pilot Project$102,318
P20 · FY2018 · CA · contact PI
1/2 Southeast Partnership for Improving Research & Training in Cancer Health Disparities$301,537
P20 · FY2017 · CA
Research Pilot Project$102,753
P20 · FY2017 · CA · contact PI
Transcriptional Control of Mcl-1 and Bok/Mtd by E2F1$270,340
R01 · FY2007 · CA · contact PI
Transcriptional Control of Mcl-1 and Bok/Mtd by E2F1$49,711
R01 · FY2007 · CA · contact PI
Transcriptional Control of Mcl-1 and Bok/Mtd by E2F1$278,413
R01 · FY2006 · CA · contact PI
Transcriptional Control of Mcl-1 and Bok/Mtd by E2F1$48,453
R01 · FY2006 · CA · contact PI
Transcriptional Control of Mcl-1 and Bok/Mtd by E2F1$285,114
R01 · FY2005 · CA
Transcriptional Control of Mcl-1 and Bok/Mtd by E2F1$47,232
R01 · FY2005 · CA
Transcriptional Control of Mcl-1 and Bok/Mtd by E2F1$285,114
R01 · FY2004 · CA
Transcriptional Control of Mcl-1 and Bok/Mtd by E2F1$43,301
R01 · FY2004 · CA
Transcriptional Control of Mcl-1 and Bok/Mtd by E2F1$281,572
R01 · FY2003 · CA
STRUCTURE, FUNCTION AND REGULATION OF E2F FAMILY$109,771
R29 · FY2001 · CA
STRUCTURE, FUNCTION AND REGULATION OF E2F FAMILY$105,706
R29 · FY2000 · CA